Harvey B Cash's Net Worth

$29.4 Million

Who is Harvey B Cash?

Harvey B Cash has an estimated net worth of $29.4 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., EnteroMedics Inc, CORGENTECH INC, AIRSPAN NETWORKS INC, Argo Group International Holdings, Ltd., Trius Therapeutics Inc, CIENA CORP, MICROTUNE INC, INTRALASE CORP, MACROGENICS INC, APPLIED GENETIC TECHNOLOGIES CORP, Transcept Pharmaceuticals Inc, SILICON LABORATORIES INC, EPOCRATES INC, ENTORIAN TECHNOLOGIES INC, FIRST ACCEPTANCE CORP /DE/, ARGONAUT GROUP INC, I2 TECHNOLOGIES INC, MYOGEN INC, and METABASIS THERAPEUTICS INC.

SEC CIK

Harvey B Cash's CIK is 0001198704

Past Insider Trading and Trends

2011 was Harvey B Cash's most active year for acquiring shares with 11 total transactions. Harvey B Cash's most active month to acquire stocks was the month of April. 2008 was Harvey B Cash's most active year for disposing of shares, totalling 12 transactions. Harvey B Cash's most active month to dispose stocks was the month of May. 2017 saw Harvey B Cash paying a total of $525,478.80 for 32,638 shares, this is the most they've acquired in one year. In 2011 Harvey B Cash cashed out on 141,200 shares for a total of $5,854,696.06, their largest year based on trade value.